Key Takeaways
- • Disha (formerly Curelink) raised Rs 43.88 crore ($4.6–$6 million) in Series A funding led by General Catalyst, with participation from existing investor Elevation Capital (Rs 5.20 crore) and Flamel Performing Creatives (Rs 48 lakh).
- • General Catalyst invested Rs 38.20 crore, establishing a 13.33% stake, while co-founders Aman Singla and Divyansh Jain retain 31.10% each, demonstrating founder-friendly capital structure and investor confidence.
- • Post-money valuation reached approximately Rs 288 crore, representing 52% growth from the previous Rs 190 crore valuation, reflecting strong momentum since the $3.5 million seed round.
- • The AI-powered health coaching platform serves 70 lakh sign-ups and 3 lakh active users across 15 chronic conditions in Hindi, English, and Hinglish, with revenue doubling to Rs 4.91 crore in FY25 versus Rs 2.47 crore in FY24.
- • Capital will fund working capital, AI model development, and geographic expansion, positioning Disha to scale its vernacular healthcare offering in India's underserved chronic-care market.
Summary
Disha, rebranded from Curelink, has secured Rs 43.88 crore in Series A funding, marking a significant milestone for the AI-powered health coaching platform targeting India's chronic-disease management market. General Catalyst led the round with Rs 38.20 crore in fresh capital, while existing investor Elevation Capital contributed Rs 5.20 crore and Flamel Performing Creatives added Rs 48 lakh. The funding round valued the company at approximately Rs 288 crore post-money, a 52% increase from its previously recorded valuation of Rs 190 crore, according to regulatory filings accessed by Entrackr.
The company operates a personalized health coaching platform offering diet, fitness, and clinical support across 15 chronic conditions, with multilingual capabilities in Hindi, English, and Hinglish. Disha has achieved significant user traction, reporting 70 lakh sign-ups, 3 lakh active users, and 1.4 crore messages exchanged on its platform. The startup claims to provide round-the-clock coaching support, differentiating its offering in the competitive digital health space.
Financial performance demonstrates momentum heading into the Series A round. Revenue nearly doubled year-over-year to Rs 4.91 crore in FY25 from Rs 2.47 crore in FY24, while losses narrowed 22.5% to Rs 4.45 crore from Rs 5.74 crore—indicating a path toward profitability and operational efficiency. The company intends to deploy capital toward working capital management, AI model advancement, and business expansion across India's larger addressable market.
Founder ownership remains concentrated with Aman Singla and Divyansh Jain each holding 31.10% post-Series A. General Catalyst's 13.33% stake and Elevation Capital's 9.96% position reflect strong institutional backing. Angel investors include Paytm founder Vijay Shekhar Sharma and ShareChat cofounder Ankush Sachdeva, each holding approximately 0.16%. The funding underscores sustained investor appetite for AI-driven, vernacular healthcare platforms addressing chronic-care management in emerging markets, particularly where language accessibility and localized health coaching remain underserved segments.
The company operates a personalized health coaching platform offering diet, fitness, and clinical support across 15 chronic conditions, with multilingual capabilities in Hindi, English, and Hinglish. Disha has achieved significant user traction, reporting 70 lakh sign-ups, 3 lakh active users, and 1.4 crore messages exchanged on its platform. The startup claims to provide round-the-clock coaching support, differentiating its offering in the competitive digital health space.
Financial performance demonstrates momentum heading into the Series A round. Revenue nearly doubled year-over-year to Rs 4.91 crore in FY25 from Rs 2.47 crore in FY24, while losses narrowed 22.5% to Rs 4.45 crore from Rs 5.74 crore—indicating a path toward profitability and operational efficiency. The company intends to deploy capital toward working capital management, AI model advancement, and business expansion across India's larger addressable market.
Founder ownership remains concentrated with Aman Singla and Divyansh Jain each holding 31.10% post-Series A. General Catalyst's 13.33% stake and Elevation Capital's 9.96% position reflect strong institutional backing. Angel investors include Paytm founder Vijay Shekhar Sharma and ShareChat cofounder Ankush Sachdeva, each holding approximately 0.16%. The funding underscores sustained investor appetite for AI-driven, vernacular healthcare platforms addressing chronic-care management in emerging markets, particularly where language accessibility and localized health coaching remain underserved segments.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.